Progenics Pharmaceuticals Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2020 to a ratio of 3.8, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2020. Average receivable collection period, for the Progenics Pharmaceuticals Inc in Mar 31 2020 quarter, has decreased to 96 days, compared to 98 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 365 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2726, from overall ranking in the fourth quarter 2019 at 3209.

What is Receivable Turnover Ratio?
What is Progenics Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PGNX Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	25.43 %	320.09 %	6.06 %	175.02 %	40.52 %
Y / Y Revenue Change	45.95 %	367.14 %	5.57 %	156.99 %	34.24 %
Receivable Turnover Ratio (TTM)	3.8	3.72	3.63	3.63	3.63
PGNX's Total Ranking	# 2726	# 3209	# 2726	# 2717	# 2675
Accounts Receivable average collection period days	96	98	101	101	100
Seq. Receivable Change	-61.25 %	158.76 %	-41.58 %	114.16 %	29.77 %
Seq. Revenue Change	-58.69 %	169.48 %	-43.68 %	132.8 %	32.21 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 118
Healthcare Sector	# 366
Overall Market	# 2726

Receivable Turnover Ratio Statistics
High	Average	Low
0.49	0.19	0.06
(Dec 31 2016)

PGNX Company Profile • Back to PGNX Efficiency Comparisons • Compare PGNX Receivables Turnover Ratio to its Competitors

Financial Statements
Progenics Pharmaceuticals Inc's Accounts Receivable	$ 6 Millions	Visit PGNX's Balance sheet
Progenics Pharmaceuticals Inc's Sales TTM	$ 37 Millions	Visit PGNX's Income Statement
Sources of PGNX's Revenues		Visit PGNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PGNX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PGNX's Growth Rates	PGNX's Roa	PGNX's Inventory Turnover Ratio	PGNX's Dividend Comparisons
PGNX's Profitability Ratios	PGNX's Roi	PGNX's Asset Turnover Ratio	PGNX's Dividend Growth
PGNX's Valuation Ratios	PGNX's Roe	PGNX's Financial Strength Ratios	PGNX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
Acura Pharmaceuticals inc	15.87	$ 3.681 Millions	$ 0.232 Millions
Cv Sciences Inc	15.67	$ 47.055 Millions	$ 3.004 Millions
Vbi Vaccines Inc	15.56	$ 2.276 Millions	$ 0.146 Millions
Ibio inc	15.27	$ 1.313 Millions	$ 0.086 Millions
Otonomy Inc	15.25	$ 0.568 Millions	$ 0.037 Millions
Albireo Pharma inc	15.15	$ 10.615 Millions	$ 0.701 Millions
Corcept Therapeutics Inc	15.09	$ 334.904 Millions	$ 22.198 Millions
Chemed Corporation	15.06	$ 1,992.319 Millions	$ 132.279 Millions
Uniqure N v	15.05	$ 6.249 Millions	$ 0.415 Millions
Sanuwave Health Inc	14.61	$ 1.499 Millions	$ 0.103 Millions
Agenus Inc	14.54	$ 85.285 Millions	$ 5.867 Millions
The Pennant Group Inc	14.30	$ 352.473 Millions	$ 24.649 Millions
Momenta Pharmaceuticals inc	14.30	$ 28.644 Millions	$ 2.003 Millions
Generex Biotechnology Corp	14.16	$ 2.027 Millions	$ 0.143 Millions
Diversicare Healthcare Services Inc	14.12	$ 460.654 Millions	$ 32.626 Millions
Mannkind Corporation	14.04	$ 61.825 Millions	$ 4.403 Millions
Imac Holdings Inc	13.76	$ 15.678 Millions	$ 1.140 Millions
Tivity Health Inc	13.69	$ 1,254.718 Millions	$ 91.663 Millions
Personalis Inc	13.57	$ 70.293 Millions	$ 5.180 Millions
Musclepharm Corporation	13.56	$ 77.123 Millions	$ 5.688 Millions
Tvardi Therapeutics Inc	13.53	$ 23.597 Millions	$ 1.745 Millions
Myomo Inc	13.51	$ 4.016 Millions	$ 0.297 Millions
Rafael Holdings Inc	13.13	$ 5.072 Millions	$ 0.386 Millions
1life Healthcare Inc	13.09	$ 292.004 Millions	$ 22.313 Millions
Kadmon holdings inc	12.97	$ 11.589 Millions	$ 0.894 Millions
Rockwell Medical inc	12.77	$ 61.600 Millions	$ 4.825 Millions
Chinook Therapeutics Inc	12.62	$ 27.270 Millions	$ 2.161 Millions
Catalyst Pharmaceuticals Inc	12.55	$ 118.994 Millions	$ 9.482 Millions
Integrated Biopharma Inc	12.47	$ 52.818 Millions	$ 4.236 Millions
Dariohealth Corp	12.45	$ 6.984 Millions	$ 0.561 Millions

Date modified: 2026-09-08T15:09:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.